Carcinoma en cuirasse

Alani, A.; Roberts, G. Hefin; Kerr, Olga

doi:10.1136/bcr-2017-222121

Cited by 5 publications

(11 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…CeC is a rare clinicopathologic type of skin metastasis with a few cases reported to date. It is more common in patients with tumor recurrence after mastectomy, radiation, or chemotherapy and characterized by diffuse sclerodermoid induration of the skin ( 7 ). The clinical presentation of CeC includes two stages.…”

Section: Discussionmentioning

confidence: 99%

Case Report: Carcinoma en Cuirasse in a Middle-Aged Woman Mimicking Postirradiation Morphea

et al. 2021

View full text Add to dashboard Cite

Breast carcinoma en cuirasse (CeC) is an extremely rare form of cutaneous metastases of breast cancer, characterized by diffuse sclerodermoid induration of the skin. It may be difficult to distinguish CeC from some skin diseases, including postirradiation morphea, inflammatory breast cancer, radiation dermatitis, and other cutaneous metastases, but it can be easily discerned by histology. Because of the small number of documented cases, the treatment consensus has not been clearly defined. Here, we show a 45-year-old woman with grade III infiltrating ductal carcinoma manifesting as CeC to the chest wall. Early diagnosis and treatment are essential to prevent the catastrophic natural progression of this rare malignancy.

show abstract

Section: Discussionmentioning

confidence: 99%

Case Report: Carcinoma en Cuirasse in a Middle-Aged Woman Mimicking Postirradiation Morphea

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Skin biopsy can aid in diagnosis 10 . Typically, carcinoma en cuirasse is a later indicator of local tumor recurrence but can also be the first presentation of occult breast cancer 9,11 …”

Section: Neoplastic Disordersmentioning

confidence: 99%

Dermatologic sequelae of breast cancer: From disease, surgery, and radiation

2020

View full text Add to dashboard Cite

The care of breast cancer patients is important to dermatologists. Breast cancer’s initial presentation, clinical progression, and its associated treatments can result in a variety of cutaneous complications. Dermatologists may be the first to identify a breast cancer diagnosis, as a subset of patients first present with direct extension of an underlying tumor or with a cutaneous metastasis. The surgical treatment of breast cancer also begets a variety of skin sequelae, including postoperative lymphedema, soft tissue infections, seromas, pyoderma gangrenosum, and scarring disorders. Moreover, breast cancer radiation treatment commonly results in skin changes, which can range from mild and temporary dermatoses to chronic and disfiguring skin ulceration, fibrosis, and necrosis. Radiation may also precipitate secondary malignancies, such as angiosarcoma, as well as rarer dermatologic diseases, such as radiation‐induced morphea, lichen planus, and postirradiation pseudosclerodermatous panniculitis. Finally, breast cancer is also associated with an array of paraneoplastic phenomena, including Sweet’s syndrome and the rarer intralymphatic histiocytosis. Herein, we review the dermatological manifestations of breast cancer, including conditions associated with its presentation, progression, and treatment sequelae. Chemotherapy‐induced cutaneous side effects are beyond the scope of this review. This article provides a comprehensive review for dermatologist to be able to identify, diagnose, and manage breast cancer patients from initial presentation to treatment monitoring and subsequent follow‐up.

show abstract

“…Although most cases are associated with primary breast cancers, carcinoma en cuirasse has been documented with primary lung, kidney, and gastrointestinal cancers. 1,2 Clinically, lesions first present as erythematous papules or nodules. As the metastatic cells begin to invade the superficial lymphatic vessels, the lesions evolve to develop a sclerotic and fibrotic appearance that may clinically resemble morphea.…”

mentioning

confidence: 99%

“…2 The decreased vascularity of the tissue makes treating carcinoma en cuirasse challenging, and there is no criterion standard therapy. 1,2,4 Current accepted strategies include hormonal interventions, chemotherapy, local irradiation, and skin grafting. 2,4 The prognosis of carcinoma en cuirasse varies widely and depends on the originating cancer.…”

mentioning

confidence: 99%

“…While carcinoma en curiasse may present as the initial manifestation of breast cancer, it more commonly develops in individuals with a known history of a breast cancer, many of whom have previously undergone treatment, such as mastectomy, chemotherapy, and radiotherapy . Given the rarity of this entity, data on specific risk factors for development are limited .…”

mentioning

confidence: 99%

See 1 more Smart Citation